Regression of Cutaneous Warts in a Patient With WILD Syndrome Following Recombinant Quadrivalent Human Papillomavirus Vaccination
- 1 October 2010
- journal article
- other
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 146 (10), 1196-1197
- https://doi.org/10.1001/archdermatol.2010.290
Abstract
In the May 2010 issue of the Archives, Venugopal and Murrell1 described a 31-year-old man who showed rapid clearance of cutaneous warts after having received 3 doses of a recombinant quadrivalent human papillomavirus (HPV) vaccination. We herein describe a severely immunosuppressed woman who experienced a similarly substantial regression of widespread cutaneous warts following vaccination with a quadrivalent HPV-6, -11, -16, and -18 vaccine.Keywords
This publication has 3 references indexed in Scilit:
- Recalcitrant Cutaneous Warts Treated With Recombinant Quadrivalent Human Papillomavirus Vaccine (Types 6, 11, 16, and 18) in a Developmentally Delayed, 31-Year-Old White ManArchives of Dermatology, 2010
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial NeoplasiaNew England Journal of Medicine, 2009
- Multiplex Human Papillomavirus Serology Based on In Situ–Purified Glutathione S-Transferase Fusion ProteinsClinical Chemistry, 2005